[Retracted] Identification of Paxillin as a Prognostic Factor for Glioblastoma via Integrated Bioinformatics Analysis

Table 1

PXN was a prognostic factor independent of recognized prognostic factors.

Parameter	Univariate cox analysis			Multivariate cox analysis
	HR	95% CI	value	HR	95% CI	value
TCGA.OS
PXN	1.069	1.031~1.107	<0.001	1.056	1.019~1.093	0.003
Age	1.026	1.012~1.041	<0.001	1.023	1.008~1.037	0.002
Gender	1.001	0.693~1.446	0.995	1.011	0.699~1.463	0.954
CGGA.OS
PXN	1.925	1.682~2.203	<0.001	1.279	1.122~1.457	<0.001
Age	1.025	1.016~1.033	<0.001	1.009	1.001~1.017	0.031
Gender	1.058	0.869~1.288	0.575	1.006	0.824~1.230	0.950
Grade	2.822	2.448~3.253	<0.001	2.243	1.898~2.651	<0.001
Radiotherapy	0.907	0.714~1.153	0.427	0.787	0.614~1.011	0.061
Chemotherapy	1.215	0.973~1.518	0.086	0.678	0.535~0.859	0.001
IDH mutation	0.325	0.265~0.397	<0.001	0.799	0.624~1.021	0.073
1p19q Codel	0.224	0.160~0.312	<0.001	0.401	0.280~0.575	<0.001
MGMT promoter methylation	0.846	0.697~1.027	0.092	0.953	0.778~1.167	0.643
GSE83300.OS
PXN	1.705	1.066~2.727	0.026	2.137	1.225~3.727	0.007
Gender	1.415	0.746~2.683	0.288	1.745	0.846~3.598	0.132
Age	1.049	1.017~1.081	0.002	1.049	1.015~1.083	0.004
TCGA.PFS
PXN	1.067	1.028~1.107	0.001	1.059	1.021~1.099	0.002
Age	1.015	1.002~1.028	0.024	1.013	0.999~1.026	0.06
Gender	1.153	0.799~1.663	0.447	1.179	0.817~1.702	0.378